(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $22.58
発行日: 15 2月 2024 @ 04:40
リターン: -39.18%
前回のシグナル: 2月 15 - 00:32
前回のシグナル:
リターン: 6.29 %
Live Chart Being Loaded With Signals
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system...
Stats | |
---|---|
本日の出来高 | 967 464 |
平均出来高 | 803 233 |
時価総額 | 586.68M |
EPS | $0 ( 2024-03-21 ) |
次の収益日 | ( $0 ) 2024-05-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.63 |
ATR14 | $0.0190 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-20 | Horn Kinney | Buy | 300 000 | Stock option (right to buy) |
2024-02-12 | Horn Kinney | Buy | 0 | |
2024-01-31 | Rosett Max | Buy | 175 000 | Stock option (right to buy) |
2024-01-31 | Stoneman Sandra G. | Buy | 200 000 | Stock option (right to buy) |
2024-01-02 | Lapetina Bob | Sell | 0 | Common Stock |
INSIDER POWER |
---|
-15.83 |
Last 93 transactions |
Buy: 3 618 517 | Sell: 4 251 388 |
ボリューム 相関
Immunome, Inc. 相関 - 通貨/商品
Immunome, Inc. 財務諸表
Annual | 2022 |
収益: | $0 |
総利益: | $-631 000 (0.00 %) |
EPS: | $-3.09 |
FY | 2022 |
収益: | $0 |
総利益: | $-631 000 (0.00 %) |
EPS: | $-3.09 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-5.63 |
FY | 2020 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-5.26 |
Financial Reports:
No articles found.
Immunome, Inc.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。